Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder

<strong>Rational<br></strong> With no available response biomarkers, matching an appropriate antidepressant to an individual can be a lengthy process. Improving understanding of processes underlying treatment responsivity in depression is crucial for facilitating work on response...

Descripció completa

Dades bibliogràfiques
Autors principals:	Martens, MAG, Filippini, N, Harmer, CJ, Godlewska, BR
Format:	Journal article
Idioma:	English
Publicat:	Springer Nature 2021

Ítems similars

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
per: Fang, F, et al.
Publicat: (2022)

Functional connectivity between task-positive networks and the left precuneus as a biomarker of response to lamotrigine in bipolar depression: a pilot study
per: Martens, M, et al.
Publicat: (2021)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
per: Mazen K Ali, et al.
Publicat: (2011-02-01)

Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder
per: Komulainen, E, et al.
Publicat: (2018)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
per: Mencacci C, et al.
Publicat: (2013-02-01)

Effective connectivity between resting-state networks in depression
per: DeMaster, D, et al.
Publicat: (2022)

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
per: Sophie R. Vaccarino, et al.
Publicat: (2024-01-01)

Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment
per: Godlewska, BR, et al.
Publicat: (2020)

A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
per: Ravi Babu. Komaram, et al.
Publicat: (2015-06-01)

Functional Connectivity between Task-Positive Networks and the Left Precuneus as a Biomarker of Response to Lamotrigine in Bipolar Depression: A Pilot Study
per: Marieke Martens, et al.
Publicat: (2021-06-01)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
per: Kishi T, et al.
Publicat: (2017-01-01)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
per: Tu Z, et al.
Publicat: (2018-09-01)

Multivariate pattern analysis strategies in detection of remitted major depressive disorder using resting state functional connectivity
per: Runa Bhaumik, et al.
Publicat: (2017-01-01)

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder
per: Dominika Jarčušková, et al.
Publicat: (2024-10-01)

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder
per: Manal E. Alkahtani, et al.
Publicat: (2021-06-01)

Escitalopram-induced akathisia in a patient with major depressive disorder: A rare case report
per: Hareem Arshad, et al.
Publicat: (2022-11-01)

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability
per: Kirino E
Publicat: (2012-12-01)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
per: Maneeton B, et al.
Publicat: (2018-08-01)

Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder
per: Emma Komulainen, et al.
Publicat: (2021-08-01)

Aberrant resting‐state functional connectivity of major depressive disorder with higher risk of suicide
per: Kazuhiro Ishikawa MD, et al.
Publicat: (2022-09-01)

Decreased resting-state functional connectivity of the habenula-cerebellar in a major depressive disorder
per: Ju-Yeon Jung, et al.
Publicat: (2022-09-01)

Abnormal resting-state functional connectivity of hippocampal subfields in patients with major depressive disorder
per: Zi Yu Hao, et al.
Publicat: (2020-02-01)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
per: Juntao Yin, et al.
Publicat: (2023-11-01)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
per: Huang J, et al.
Publicat: (2018-09-01)

Abnormal resting-state functional connectivity in subregions of amygdala in adults and adolescents with major depressive disorder
per: Lin Guan, et al.
Publicat: (2024-07-01)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
per: K.H. Lee, et al.
Publicat: (2022-06-01)

Individualized resting-state functional connectivity abnormalities unveil two major depressive disorder subtypes with contrasting abnormal patterns of abnormality
per: Keke Fang, et al.
Publicat: (2025-02-01)

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
per: Jeong JH, et al.
Publicat: (2015-10-01)

Comparison of the Effect of Sertraline and Escitalopram on the Treatment of Major Depressive Disorder in Hemodialysis Patients: A Randomized Controlled Trial
per: Tahereh Sabaghian, et al.
Publicat: (2024-09-01)

Review of the brain areas activated in fMRI after escitalopram antidepressant treatment inpatients with major depressive disorder
per: Mao Yi, et al.
Publicat: (2021-08-01)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
per: Lönnqvist Jouko, et al.
Publicat: (2008-10-01)

Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India
per: Tatiyana Mandal, et al.
Publicat: (2021-03-01)

Short-term escitalopram treatment and hippocampal volume.
per: Godlewska, B, et al.
Publicat: (2014)

A Study about Escitalopram Versus Citalopram in the Treatment of Depressive Disorders
per: Jasim M. Shindi, et al.
Publicat: (2015-08-01)

Alterations in electroencephalographic functional connectivity in individuals with major depressive disorder: a resting-state electroencephalogram study
per: Yingtan Wang, et al.
Publicat: (2024-07-01)

Resting-state functional connectivity of the raphe nuclei in major depressive Disorder: A Multi-site study
per: Yajuan Zhang, et al.
Publicat: (2023-01-01)

Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis
per: Zhang Liu, et al.
Publicat: (2024-01-01)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
per: Pattath Narayanan Suresh Kumar, et al.
Publicat: (2023-01-01)

CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
per: Rodrigo Bernini de Brito, et al.
Publicat: (2020-05-01)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
per: Yanxiang Ye, et al.
Publicat: (2022-01-01)